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Abstract  
Introduction: Rotavirus causes severe-diarrheal diseases in infants. An estimation of 138 million rotavirus-associated diarrheal cases and 215,000 
deaths occur every year globally. In December 2016, West-Shewa zone in Ethiopia reported unidentified gastrointestinal diarrhea outbreak. We 
investigated to identify the causative agent of the outbreak to support response operations. Methods: Medical records were reviewed, and the 
daily line list was collected from health facilities. Descriptive data analysis was done by time, person and place. Stool specimens were first tested 
by antigen capture enzyme immunoassay (EIA) technique and further confirmed by reverse-transcription polymerase chain reaction (RT-PCR) as a 
gold standard. The product of RT-PCR was genotyped for each gene using G1-G4, G8-G9 and G12 primers for VP7 gene and P(4), P(6), P(8) and 
P(14) primers for VP4 gene. Results: A total of 1,987 diarrheal cases (5.7 per 1000) and five deaths (case-fatality rate 0.25%) were identified and 
epidemiologically-linked to confirmed rotavirus from December 2016 to February 2017. Among the cases, 1,946 (98%) were < 5 children. Fourteen 
(74%) of the 19 tested stool specimens were positive for rotavirus by EIA and RT-PCR. Majority of strains detected were G12P(6) (25%) and G-
negative P(8) (25%) followed by G9P(8) (19%), G1P(8) (13%) and G3/G2 P(8), G12P(8), and G-negative P(6) (6% each). Conclusion: Diarrheal 
outbreak which occurred in West-Shewa zone of Ethiopia was associated with rotavirus and relatively more affected districts with low vaccination 
coverage. Routine rotavirus vaccination quality and coverage should be evaluated and the surveillance system needs to be strengthened to detect, 
prevent and control a similar outbreak. 
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Introduction 
 
Rotavirus is a genus Rotavirus in the family Reoviridae and causes 
severe diarrhea and vomiting in infants [1]. Rotavirus has a genome 
consisting of 11 segments of double-stranded RNA [2, 3]. Most 
segments encode a single polypeptide, allowing the virus to express 
six structural viral proteins (VP1-VP7) and six nonstructural proteins 
(NSP1- NSP6) [3]. Rotavirus-infected persons shed high 
concentrations of rotavirus in the stool. The disease transmits from 
an infected person to another by fecal-oral route through close 
person-to-person contact and by fomites. Less commonly, the virus 
is transmitted by consuming contaminated water or food [4]. 
Rotavirus is stable and may persist viably in the environment for 
weeks or even for months if not disinfected [4-6]. Individuals 
infected by rotavirus disease manifest some watery diarrhea of 
limited duration to severe diarrhea with vomiting and fever that can 
result in dehydration with shock, electrolyte imbalance and even 
death [7]. Following an incubation period of 1-3 days, the illness 
often begins shortly and vomiting frequently precedes the onset of 
diarrhea. The gastrointestinal symptoms usually resolved in 3-7 days 
after the first onset of the illness [8]. Rotavirus is the most common 
cause of severe, dehydrating gastroenteritis in infants and young 
children worldwide [9]. An estimated 138 million annual cases and 
215,000 deaths in under five children reported in both developing 
and developed countries, principally in Asia and sub-Saharan Africa 
[10-12]. Rotavirus infection accounts for 40% of childhood 
gastroenteritis hospitalizations and 37% of diarrhea-related deaths 
in children under five years old [13]. Diarrheal disease is a leading 
killer and causing approximately 16 percent of deaths in children 
less than five years of age in Ethiopia [14]. Rotavirus is one of the 
top diarrhea diseases and affect the lives of more than 28,000 
Ethiopian children of under five years old every year [15] which 
makes Ethiopia one of the five developing countries accounted for 
more than half of all rotavirus deaths: The Democratic Republic of 
the Congo, Ethiopia, India, Nigeria and Pakistan [16, 17]. 
  
Diarrheal diseases caused by rotavirus cannot be clinically 
differentiated from that caused by other enteric pathogens; specific 
diagnosis needs testing of fecal specimens with commercially 
available assays [7]. ELISA, Test device and Latex Agglutination 
tests are a sensitive diagnostic test for rotavirus detection [18]. 
However, PCR provided the best overall sensitivity and specificity 
[19]. This diagnostic testing technique is not usually available for 
routine patient management. At the hospital level, routine 
laboratory confirmation is not usually performed as the clinical 
management mostly relies on appropriate rehydration therapy. 
Hospital-based rotavirus surveillance in under five children was 
initiated in 2007 in Addis Ababa to estimate the burden of rotavirus 
gastroenteritis in children less than five years of age. Studies have 
shown that rotavirus accounts for 18%-28% of diarrhea 
hospitalizations among children < 5 years of age in Ethiopia [20-
23]. Ethiopia introduced the Rotarix vaccine into its routine 
immunization program in November 2013 with two doses in 6 and 
10 weeks of age [15, 24]. The WHO required 90% and 80% 
vaccination coverage at the national and district level respectively 
for all vaccine-preventable diseases including rotavirus [25]. In 
Ethiopia, the national rotavirus vaccination coverage was 56.0% 
while it was 50.2% in Oromia region that included West Shewa in 
2016 [26]. In pre-vaccine period (2007-2011), the most prevalently 
detected genotypes in Addis Ababa were G1P(8) (20%), G12P(8) 
(17%) and G3P(6) (15%) [27]. In the 2nd week of December 2016, 
West Shewa zone of Oromia regional state reported rotavirus 
suspected acute diarrhea outbreak. As the number of daily cases 
increasing the investigation was warranted and conducted to 
identify the underlying causative agent of the outbreak to support 





West Shewa zone is one of the zones in Oromia regional state of 
Ethiopia to the west of Addis Ababa. Based on the 2007 Census 
conducted by the Central Statistical Agency of Ethiopia (CSA), this 
Zone has a total population of 2,058,676, of which 1,028,501 are 
men, and 1,030,175 are women. The investigation was warranted 
by the Ethiopian Public Health Institute as part of outbreak response 
and management. Subsequent permissions obtained from Oromia 
Regional Health Bureau, West Shewa Health Department, Nono, 
Danno and Jibat districts health offices to investigate the outbreak. 
The outbreak case definition for rotavirus was "any person 
presenting to a health facility with acute diarrhea and/ or vomiting 
or any person in which clinician suspected rotavirus in Nonno, 
Danno, Jibat districts after December 16, 2016." Clinicians were 
reported cases met the case definition for the duration of the 
outbreak. Medical records were reviewed and all cases were line 
listed up on getting verbal permission from medical directors of 
health facilities. Patients' age, outbreak area setting, contact history, 
and date of symptoms of onset were used to epidemiologically link 
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gastrointestinal diarrheal cases with laboratory-confirmed rotavirus 
cases. The descriptive cross-sectional study design was employed, 
and data analysis was done by time, person and place using 
Microsoft Excel. The incident rate was calculated by dividing the 
number of the case to the population (Source: 2007 Census) and 
expressed per 1,000. The age-specific incident rates were also 
calculated by dividing the number of cases within a specific age 
group or sex to respective age group population and multiplying by 
1,000. Three years of routine rotavirus vaccination coverage data 
were received from West Shewa Health Department and compared 
with suspected rotavirus incidence rate. Incident rate and 
vaccination coverage were depicted on the map using the Arc 
Geographic Information System (Arc GIS) 10.4.1 version to illustrate 
the most affected districts. 
  
Rotavirus infection was determined by using an antigen capture 
enzyme immunoassay (EIA; ProSpecTTMRotavirus kit, Oxoid Ltd, 
United Kingdom) on the collected 19 fecal specimens at the national 
laboratory of the Ethiopian Public Health Institute (EPHI). RT-PCR 
was used as a gold standard for further confirmation and 
genotyping. All positive samples were further characterized by 
molecular methods at the Rotavirus Regional Reference Laboratory 
(RRRL): South Africa Medical Research Council (SAMRC) Diarrheal 
Pathogens Research Unit, Department of Virology, SefakoMakgatho 
Health Sciences University, Pretoria, South Africa. As described 
before, the VP7 and VP4 genes were amplified by reverse 
transcription polymerase chain reaction (RT-PCR) using the outer 
primer sets sBeg/End9 and Con2/Con3 [28, 29]. RT-PCR products 
for each gene were genotyped using type-specific primers such as 
G1-G4, G8-G9, and G12 for VP7 gene and primers P(4), P(6), P(8) 
and P(14) for VP4 gene, respectively. The investigation was 
conducted to support the response operations or management of 
the outbreak by identifying the causative agent so as to pinpoint 
and specify the interventions. Ethiopian public health Institute is 
mandated by the Council of Ministers to conduct diseases 
surveillance, epidemiological and laboratory investigations and 





A total of 1,987 diarrheal cases (5.7 per 1,000) and five deaths 
(case fatality rate 0.25%) were identified and epidemiologically 
linked to confirmed rotavirus from 16 December 2016 to 21 
February 2017. Among the cases, 1121 (56%) were male, and the 
rest of 866 (44%) cases were female (Table 1). Only 32 (1.6%) of 
the cases were hospitalized. The majority of the cases, 1946 (98%), 
were under the age of five years old with nine months median age 
and interquartile range 14 months (Q1 = 6 months and Q3 = 20 
months). A total of 19 stool specimens were collected during the 
diarrhea outbreak in the affected districts. All children sampled were 
with unknown rotavirus vaccination history. Among the collected 
samples, 14 (74%) were positive for rotavirus by EIA. Male and 
female contribute 7 (50%) each of the positive cases (Table 1). 
With regard to genotyping results, majority of the strains found 
were G12P(6) (25%) and G-negative P(8) (25%) followed by 
G9P(8) (19%),G1P(8) (13%) and G3/G2 P(8), G12P(8) and G-
negative P(6) (6% each), respectively. The crude incidence rate was 
5.7 cases per 1,000 populations with some variation among 
different affected districts. Nonno is the most affected district with 
the incident rate of 8.5 cases per 1,000 populations. The age group 
specific incident rate showed that young children less than five 
years of age were the most affected age groups with the incident 
rate of 38.2 cases per 1,000 populations of the same age (Table 2). 
The outbreak started in the 2nd week of December 2016 in Nonno 
district. It was further spread to Danno and Jibat districts of West 
Shewa zone and increased to reach high pick on the 3rd week of 
January 2017 and the number of daily cases started dropping in the 
same week until the 3rd week of February 2017 (Figure 1). Among 
total cases, 1224 (62%) were not vaccinated for rotavirus; 693 
(35%) were vaccinated while the vaccination statuses of 70 (4%) of 
the cases were not known (Table 3). Routine rotavirus vaccination 
coverage was relatively low in Nonno district followed in Danno 
District over years (Table 4). The 2016/2017 routine 2nd dose 





This is first reported and investigated rotavirus-associated diarrheal 
outbreak occurred in three districts of West Shewa Zone of Oromia 
Region in Ethiopia. The diarrheal outbreak affected the health of 
many children is associated with rotavirus where 62% of the cases 
were not vaccinated. In sub-Saharan Africa 45.5% in 2000 and 
38.9% in 2013 deaths of diarrheal diseases attributed to rotavirus 
[31]. Children aged less than five years old were most affected (38 
cases per 1,000 populations) by the outbreak with a median age of 
nine months. Children under five years of age are most vulnerable 
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to the disease [10]. In low-income countries, the median age at the 
primary rotavirus infection ranges from 6 to 9 months [32, 33]. 
Similar to our observation, in the Solomon Islands at which the 
highest attack rate during the outbreak occurred in the < 5 years 
age groups (32%), which was > 14 times higher than in the ≥ 5 
years age groups (2%) [34]. During this outbreak children under 
five years account for 98% of the total cases which is supported by 
a study conducted in South Tarawa, Kiribati, that indicates 93.4% of 
the cases attributed to the rotavirus outbreak and all deaths were 
under five years old [10]. AS compared with the 2.5% rotavirus CFR 
estimated by WHO, the CFR we reported here is low [35]. Another 
study in Ethiopia also reported 2.4% CFR due to rotavirus which is 
higher as compared to our report [36]. The lower CFR in our 
investigation might be attributed to the early detection and 
treatment of cases at health facilities. In our investigation, we 
observed G12P(6) and G-negative P(8), G9P(8) were circulating 
dominantly followed by G1P(8), G3/G2 P(8), G12P(8), and G-
negative P(6) in the outbreak areas. Whereas, the previous study 
showed that G3P (6), G1P (8) and G2P (4) are common strains of 
rotaviruses circulating in Ethiopia [10, 22, 31, 37]. In rural Southern 
Ethiopia, it was reported that 43.6% of children less than five years 
of age had diarrhea as a result of rotavirus [38]. 
  
G-P combinations such as G1P(8), G2P(4), G3P(8), G4P(8) and 
G9P(8) contribute about 90% of all human rotavirus infections in 
which G1P(8) is the most prevalent combination worldwide. 
Surveillance studies indicate that G1P(8) strain contribute 52.2% of 
rotavirus strains globally and 17.4% in Africa [39]. Several rotavirus 
types are circulating in Asia and Africa with greater strain diversity. 
Among the total rotavirus cases, 52.1%, 28.9% and 16.9% cases 
were reported with the history of at least one dose of rotavirus 
vaccination in Nonno, Jibat and Danno districts respectively. The 
proportion of infected vaccinated children is high in Nonno district 
which might be attributed to the quality of vaccination. The study 
conducted in the Republic of Moldova indicates that 25% moderate 
to severe cases received at least one dose of rotavirus vaccine [40]. 
The case-control studies conducted in Malawi and Botswana indicate 
that rotavirus vaccine efficacy for two doses were 64% and 54% 
respectively which is low compared with developed countries 
[41, 42]. The administrative vaccination coverage for the last three 
years varies from district to district. In contrast to the vaccination 
status of the patients, the vaccination coverage was low in Nonno 
district. Nonno was the most affected district with a high number of 
cases and incidence rate. In the district vaccination coverage for the 
2nd dose of rotavirus vaccine was 81% in 2015/2016 and 67% in 
2016/2017 which was less than the World Health Organization's 
minimum requirement [25, 43]. Similarly, the vaccination coverage 
in Danno district was less to prevent the outbreak. However, the 
rotavirus vaccination coverage was high in Jibat district. In Jibat 
district effectiveness of the vaccine needs to be further studied and 
evaluated. Even though rotavirus vaccine efficacy is actually high, 
the effectiveness of rotavirus vaccine is less in developing countries 
as compared with developed countries [44]. We also believe that, as 
the reliability of the administrative vaccination concerns, the true 
vaccination coverage even might be less than what was reported 





The diarrheal outbreak occurred in three districts of South West 
Shewa zone of Oromia region in Ethiopia was associated with 
different rotavirus strains and relatively more affected districts with 
low vaccination coverage. The existing routine rotavirus vaccination 
needs to be evaluated and the surveillance system needs to be 
strengthened to detect, prevent and control a similar future 
outbreak. 
 
What is known about this topic 
 Rotavirus is the most common cause of severe 
gastroenteritis and responsible for more than one-third of 
diarrheal diseases related to hospitalizations and deaths in 
infants under five years old. Currently, there is a safe and 
effective vaccine to prevent rotavirus infections. 
What this study adds 
 Rotavirus caused diarrheal disease outbreak and mostly 
affected under five years children in West Shewa Zone of 
Oromia Region of Ethiopia. The occurrence of the 
outbreak suggested there is an inadequate rotavirus 
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Laboratory test results 
Total Female Male Sample Positive Positivity Rate 
Danno 914 395 519 0 11 7 63.6% 
Nonno 983 436 547 0 - - - 
Jibat 90 35 55 5 8 7 87.5% 




Table 2: Rotavirus cases incident rate per 1,000 populations by age groups and districts, West Shewa Zone, Oromia Region, 
Ethiopia, 2017 
District 0-4 Years 5-14 Years 15-44 Years 45 and above Years Total 
Danno 887 (44.6%) 13 (0.3%) 13 (0.2%) 1 (0.1%) 914 (6.7%) 
Nonno 971 (57.7%) 7 (0.2%) 5 (0.1%) 0 (0.0%) 983 (8.5%) 
Jibat 88 (6.2%) 2 (0.1%) 0 (0.0%) 0 (0.0%) 90 (0.9%) 





Table 3: Rotavirus vaccination status of the cases, West Shewa Zone, Oromia Region, Ethiopia, 2017 
District Unknown Unvaccinated Vaccinated Total 
Danno 4 (0.4%) 755 (82.6%) 155 (16.9%) 914 (100%) 
Nonno 19 (1.9%) 452 (46.0%) 512 (52.1%) 983 (100%) 
Jibat 47 (52.2 17 (18.9%) 26 (28.9%) 90 (100%) 




Table 4: Routine rotavirus vaccination administrative coverage by district, West Shewa Zone, Oromia Region, Ethiopia, 2014-2017 
District 
2014/2015 2015/2016 2016/2017 
1st dose % 2nd dose % 1st dose % 2nd dose % 1st dose % 2nd dose % 
Danno 106 95 101 88 87 72 
Nonno 97 92 99 81 76 67 
Jibat 101 96 106 98 106 95 




































Figure 2: Map of Ethiopian showing rotavirus incidence rate and rotavirus vaccination coverage by districts, 2017 
 
